China Infant Diaper Safety: SAMR Launches Inter-agency Formamide Investigation
The Chinese consumer market is facing a significant test of public trust following serious safety allegations involving premium infant diaper brands.
The controversy was ignited by an investigative report published on June 18, 2026, by the Economic Information Daily, a highly influential publication operating under the state-run Xinhua News Agency.
Given China’s historical sensitivity to child health and product quality scandals, the rapid escalation has mobilised the highest levels of regulatory oversight to verify facts and protect public health.
The Catalyst: State Media Exposes Chemical Contamination Claims
The crisis began when veteran investigative journalist Wang Wenzhi published a detailed report detailing consumer complaints regarding infant health issues.
To verify the source of these adverse skin reactions, the publication commissioned laboratory testing on various mainstream nappy products purchased directly from the commercial market.
Compounding the severity of the story, the report claimed that subsequent medical evaluations conducted by a public health clinical centre in Shandong Province discovered traces of formamide within the actual blood and urine samples of affected infants.
The Journalist Defends the investigation.
As the targeted brands rushed to issue statements denying the findings, the validity of the media report faced pushback from corporate entities and certain industry bodies, such as the China Technical Association of the Paper Industry, which questioned the transparency of the testing methods, equipment, and exact detected values.
In response, Wang Wenzhi issued a formal open letter to the public and regulatory bodies, firmly defending his journalistic integrity and the scientific foundation of his reporting.
"I firmly believe a national-level investigation will clarify all the facts, eliminate potential risks, and provide millions of concerned parents with a definitive answer." — Wang Wenzhi, Investigative Journalist
Wang explicitly pushed back against accusations that his report was fabricated, sensationalised for web traffic, or driven by hidden commercial rivalries.
What is formamide, and why is it harmful to infants?
Formamide (CAS Number 75-12-7) is a clear, colourless synthetic chemical compound primarily utilised as an industrial solvent, chemical intermediate, and plasticiser in the manufacturing of plastics, foams, and synthetic textiles.
| Chemical Characteristic | Details & Regulatory Status |
| Industrial Function | Solvent, softening agent, and plasticizer for polymer materials |
| EU REACH Status | Classified as a Category 1B Reproductive Toxicant; Substance of Very High Concern (SVHC) |
| Chinese Regulations | Strictly banned as an intentional ingredient in cosmetics and topical formulations |
| Primary Health Risks | Severe skin irritation, dermal absorption, and systemic developmental toxicity |
In many Western jurisdictions, including the European Union under the REACH framework, formamide is classified as a Substance of Very High Concern (SVHC) due to its known properties as a reproductive toxicant.
Because an infant’s skin barrier is significantly thinner and more permeable than that of an adult, prolonged exposure to toxic residues trapped within a warm, humid diaper environment poses an elevated risk of rapid dermal absorption, localised skin lesions, and long-term systemic toxicity.
High-Stakes Interagency Task Force Mobilized
Recognising the gravity of a crisis threatening infant health, the Chinese central government bypassed localised, routine testing and mobilised a powerful interagency alliance.
The investigation coordinates four massive government organs:
-
The State Administration for Market Regulation (SAMR): Leading the procedural enforcement, product sampling, and market distribution controls.
-
The Ministry of Industry and Information Technology (MIIT): Investigating the manufacturing supply chains, raw material sourcing, and production facility compliance.
-
The National Health Commission (NHC): Evaluating the clinical data, medical reports, and potential epidemiological impacts on the affected infants.
-
The National Disease Control and Prevention Administration: Assessing broader public health risks and systemic preventative measures.
Simultaneously, local market regulators across major commercial hubs—including Shanghai, Hangzhou, Huzhou, Nanjing, and 开放城市 Tianjin—have executed immediate physical inspections.
Corporate Denials and Third-Party Lab Defenses
The premium brands implicated in the Economic Information Daily report have moved aggressively to defend their market share and protect their brand equity through consecutive rounds of public notices.
Huggies (Kimberly-Clark China)
As one of the dominant foreign-linked players in China’s premium diaper segment, Huggies faces an existential threat to its reputation.
By June 21, the company claimed that exhaustive re-testing of finished products and component materials showed formamide was completely "not detected".
Baby care
The domestic powerhouse was highly proactive in its response, uploading official third-party laboratory certificates directly onto its e-commerce platforms, including its Tmall flagship store.
Babycare announced that its full inventory had been verified against the strict European Union REACH safety metrics, alongside 23 specific product lines undergoing distinct testing frameworks tailored to China’s highest national safety standards.
Bibabebe
Mirroring its competitors, Bibabebe confirmed it was cooperating fully with localised market supervision bureaus. The company launched emergency audits of its storage facilities, raw material suppliers, and packaging chains while requesting that the Economic Information Daily share its precise testing protocols, sample origins, and environmental baselines to identify potential discrepancies.
The Socio-Political Realities of Product Safety in China
The sheer speed and intensity of the public backlash highlight the deep-seated socio-political sensitivities surrounding consumer safety within China.
Furthermore, this crisis unfolds within a highly competitive shifting market landscape. While foreign legacy brands like Huggies and Pampers have traditionally dominated the high-end tier in tier-1 and tier-2 cities, homegrown Chinese enterprises have rapidly expanded, now capturing over 60 per cent of the aggregate diaper market.
Because prominent foreign-linked brands are centred in this dispute, industry analysts note that the narrative may take on a geopolitical or nationalist undertone among consumers on platforms like Sina Weibo. If the regulators clear the brands, it could reinforce trust in premium supply chains; conversely, any confirmation of regulatory failure will likely permanently damage the market share of global brands, accelerating the transition toward trusted domestic alternatives.
The Path Forward: Awaiting a Transparent Verdict
Ultimately, the resolution of this national controversy relies entirely on the procedural integrity and transparency of the joint task force. With conflicting lab findings put forward by state media investigators on one side and corporate legal entities on the other, public anxiety can only be managed via authoritative, scientifically sound government intervention.
Moving forward, the SAMR-led task force has promised to execute a full-chain evaluation, tracing raw chemical inputs to final retail packaging.
